Country: Malta
Language: English
Source: Medicines Authority
CROMOGLICATE SODIUM
Sanofi S.R.L Viale L. Bodio, 37/b 20158, Milan, Italy
S01GX01
CROMOGLICATE SODIUM 2 % (W/V)
EYE DROPS, SOLUTION
CROMOGLICATE SODIUM 2 % (W/V)
OTC
OPHTHALMOLOGICALS
Withdrawn
2006-03-06
A. PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER OPTICROM ALLERGY SINGLE DOSE, 2 % W/V EYE DROPS SOLUTION sodium cromoglicate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET 1. What Opticrom Single Dose is and what it is used for 2. What you need to know before you use Opticrom Single Dose 3. How to use Opticrom Single Dose 4. Possible side effects 5. How to store Opticrom Single Dose 6. Contents of the pack and other information 1. WHAT OPTICROM SINGLE DOSE IS AND WHAT IT IS USED FOR Opticrom Allergy Single Dose, 2 % w/v Eye Drops solution (called Opticrom Single Dose in this leaflet) contains a medicine called sodium cromoglicate. This belongs to a group of medicines called anti-allergics. WHAT OPTICROM SINGLE DOSE IS USED FOR Opticrom Single Dose is used to relieve and treat eye allergies in adults and children. There are two types of eye allergy: • ‘perennial allergic conjunctivitis’ – this can happen at any time of the year • ‘hay fever’ or ‘seasonal allergic conjunctivitis’ – this happens in different seasons and is caused by different pollens. Signs of allergies include itchy, watery, red or inflamed eyes and puffy eyelids. HOW OPTICROM SINGLE DOSE WORKS Opticrom Single Dose works by stopping the release of the natural substances in your eyes – these are the cause of the allergic reaction. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE OPTICROM SINGLE DOSE DO NOT USE OPTICROM SINGLE DOSE: • if you are allergic to sodium cromoglicate or any of t Read the complete document
ANNEX 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Opticrom Allergy Single Dose 2%w/v Eye Drops, solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each single dose container contains 2.0% w/v of sodium cromoglicate. For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Eye drops, solution A clear colourless or pale yellow liquid. pH: 5.0 to 7.0 Osmolality: 280 to 340 mOsmol/kg 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief and treatment of seasonal and perennial allergic conjunctivitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and children _ The recommended dose is one or two drops in each eye four times a day. Opticrom Single Dose should be used regularly to ensure optimal control of symptoms. It is recommended that treatment is continued during the period of exposure to allergen. Special population _Older people _ No current evidence for alteration of the dose. _Paediatric _ In children, caregiver supervision and/or assistance may be required. Method of administration For ocular use only. It should be administered in the conjunctival sac of the affected eye. To avoid contamination, the tip of the container should not touch the eye or any surface (see section 4.4). As with most ophthalmic preparations, contact lenses should be removed before each application and may be inserted after 15 minutes. In case of concomitant treatment with other eye drops, instillations should be 15 minutes apart. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE Opticrom Single Dose is sterile, preservative-free, and presented in a single dose container which should be used immediately after opening and any remaining contents discarded after use. Patients wearing contact lenses: see section 4.2. 4.5 INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION No interactions studies have been performed. 4.6 FERTILITY, PREGNA Read the complete document